Conjugated estrogens and bazedoxifene

about

Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community.

P2860

Q55293755-412F07E2-3031-47AC-BEE7-0DD99A4ADB83

P2860

Conjugated estrogens and bazedoxifene

Item

http://www.wikidata.org/entity/Q37676345

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Conjugated estrogens and bazedoxifene

@en

Conjugated estrogens and bazedoxifene.

@nl

type

Item

label

Conjugated estrogens and bazedoxifene

@en

Conjugated estrogens and bazedoxifene.

@nl

prefLabel

Conjugated estrogens and bazedoxifene

@en

Conjugated estrogens and bazedoxifene.

@nl

P1476

Conjugated estrogens and bazedoxifene

@en

P2093

Danial E Baker

http://www.w3.org/2001/XMLSchema#string

Dennis J Cada

http://www.w3.org/2001/XMLSchema#string

P2860

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Breast density changes in a randomized controlled trial evaluating bazedoxifene/conjugated estrogens.

Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.

Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis.

Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity.

Effects of bazedoxifene/conjugated estrogens on quality of life in postmenopausal women with symptoms of vulvar/vaginal atrophy.

Sustained efficacy and safety of bazedoxifene in preventing fractures in postmenopausal women with osteoporosis: results of a 5-year, randomized, placebo-controlled study.

Hot flush symptom-free days with bazedoxifene/conjugated estrogens in postmenopausal women.

Bazedoxifene/conjugated estrogens (BZA/CE): incidence of uterine bleeding in postmenopausal women.

P304

273-283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1310/HPJ4903-273

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24715748

http://www.w3.org/2001/XMLSchema#string

P932

3971114

http://www.w3.org/2001/XMLSchema#string

Conjugated estrogens and bazedoxifene

about

P2860

P2860

Conjugated estrogens and bazedoxifene

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932